In this article, we demonstrate that conolidine, a normal analgesic alkaloid used in conventional Chinese drugs, targets ACKR3, therefore delivering additional proof of a correlation between ACKR3 and soreness modulation and opening choice therapeutic avenues for that treatment method of chronic